Tag Archives: Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc. [NASDAQ: BLCM]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Bellicum Pharmaceuticals, Inc. Oklahoma City, OK (February 12, 2018) – On February 6, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of Texas against Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM). The complaint… Read More »